|
Match
|
Document |
Document Title |
|
|
5472705 |
Pharmaceutical composition containing esters of ω-3 polyunsaturated acids and their use in the topical treatment of morbid affections
New pharmaceutical compositions for topical use containing esters of ω-3 polyunsaturated acids having a high concentration have been obtained. Such formulations have been added with phenolic...
|
|
|
5466714 |
Spermicidal and cytocidal fatty acid compositions
This invention is directed to spermicidal or cytocidal activity of fatty acids and monoglycerides. More particularly, this invention is directed to the killing of sperm and cells by fatty acids and...
|
|
|
5464805 |
Method of controlling mildew in cultivated plants
The present invention provides a method for controlling mildew in cultivated crops. The aqueous fungicide formulation which is applied to pre-harvest and post-harvest crops contains ingredients...
|
|
|
5462726 |
Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A.sub.2 receptor antagonist and pharmaceutical compositions containing such solvents
A method is provided for inhibiting or preventing toxicity and other unwanted effects (a) caused by solvents for pharmaceuticals which solvents contain castor oil or ricinoleic acid or derivatives...
|
|
|
5462967 |
Feed additive for livestock and feed for livestock
A feed additive which is effective for preventing and/or treating protozoiasis of livestock such as coccidiosis and for suppressing accumulation of fat of livestock is disclosed, which comprises...
|
|
|
5457130 |
Eicosapentaenoic acid used to treat cachexia
The use of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid or EPA, preferably substantially free of any other polyunsaturated fatty acids, is disclosed for making up medical...
|
|
|
5456912 |
Non-methylene interrupted fatty acids as immunomodulators
Autoimmune diseases are controlled by the administration of non-methylene interrupted fatty acids of the formula ##STR1## in which R is alkyl or alkenyl. A preferred compound within the scope of...
|
|
|
5455035 |
Clear two-phase cosmetic composition
A cosmetic product formed as a multi-compartment dispenser is provided wherein a first and second substance is stored apart from one another in separate compartments. The first substance...
|
|
|
5443844 |
Linoleic acid preparations for topical treatment of acne vulgaris
A preparation for topical application of linoleic acid, for treatment of acne, and Propionibacteriem acnes, contains between about 0.1% and about 10%, preferably between about 1% and about 5% and...
|
|
|
5444092 |
Method and composition for treating psoriasis
A novel skin lotion consisting of a mixture of lye, oils, alcohol, coal tar, and menthol U.S.P. The mixture provides a cleansing lotion that readily treats psoriasis. When the mixture is applied to...
|
|
|
5436269 |
Method for treating hepatitis
A drug for hepatic diseases, particularly an ameliorant for hepatic functions and a drug for hepatitis, containing docosahexaenoic acid or a derivative thereof (DHA) as an active ingredient. The...
|
|
|
5434183 |
Phospholipids containing omega-3-fatty acids
The invention relates to an emulsion which comprises phospholipids containing omega-3-fatty acids such as DHA and EPA in a high amount and a vegetable oil and/or marine oil. It also relates to the...
|
|
|
5432148 |
Slow-release ammonium bicarbonate fungicide compositions
This invention provides a fungicide composition which is capable of in situ generation of ammonium bicarbonate when applied to plant foliage in the form of an aqueous dispersion. The constituents...
|
|
|
5432146 |
Free-flowing bicarbonate fungicide compositions
The present invention provides a fungicidal fertilizer composition which contains ingredients which are biocompatible for purposes of agricultural applications, and which are harmless to animals...
|
|
|
5428072 |
Method of increasing the efficiency of feed conversion in animals
A method of enhancing weight gain and feed efficiency in an animal which comprises administering to the animal a safe and effective amount of a conjugated linoleic acid.
|
|
|
5425938 |
Polyamino salts of alpha-hydroxyacids, alpha-ketoacids and related compounds
Cosmetic compositions are described wherein α-hydroxyacids, α-ketoacids and related compounds are formed into amine salts through neutralization with a multi-amine functionalized polymer....
|
|
|
5424270 |
Bicarbonate fungicide compositions containing spreader-sticker ingredients
The present invention provides a method for controlling fungal disease in plants with a fungicidal fertilizer composition which contains ingredients which are biocompatible for purposes of...
|
|
|
5419908 |
Sanitizing composition comprising a blend of aromatic and polyunsaturated carboxylic acids
The invention generally comprises a composition capable of sanitizing and disinfecting antimicrobial efficacy while also being ingestible as a food additive residue by humans and mammals....
|
|
|
5416115 |
Method for regulating milk fat and milk production using trans-fatty acids
The present invention pertains to reducing milk fat levels optionally to enhancing overall milk yields in ruminants by administration of trans-fatty acids, trans-fatty acid salts, amides, and...
|
|
|
5416116 |
Pediculicidal medicaments comprising derivatives of undecylenic/undecanoic acids
Methods for the treatment of pediculosis are disclosed comprising applying a pediculicidally effective amount of at least one metal salt or ester of undecylenic acid in combination with a...
|
|
|
5415879 |
Method of reducing heart related disease in humans using eggs having relatively high percentage of long chain fatty acids
Chickens are fed a composition including fish oil over a period of time. Modified eggs laid by such chickens contain substantial quantities of omega-3 polyunsaturated fatty acids. The modified eggs...
|
|
|
5411988 |
Compositions and methods for inhibiting inflammation and adhesion formation
There is disclosed compositions and methods for inhibiting inflammation and/or adhesion formation in a patient. The compositions comprise omega-3 and/or omega-6 fatty acids, a nonionic surfactant,...
|
|
|
5409955 |
Compositions and methods for inhibiting uterine contractility
There is disclosed a composition for inhibiting uterine contractility by topical or local administration. The composition contains an omega fatty acid in combination with a cyclo-oxygenase...
|
|
|
5395851 |
Tree wound coating composition
A coating composition for application to tree wounds, such as pruning wounds of living trees is provided. The composition is non-phytotoxic and provides extended protection against fungal...
|
|
|
5393522 |
Compositions for the control of pepper weevils
Synthetically prepared pheromone compositions, prepared from various mixtures of (Z)-3,3-dimethyl-Δ 1 ,β -cyclohexane ethanol, (E)-3,3-dimethyl Δ 1 ,β -cyclohexane ethanol, (Z)-3,3-dimethyl-Δ...
|
|
|
5391548 |
Transdermal flux enhancing compositions to treat hypertension, diabetes and angina pectoris
A transdermal flux enhancing pharmaceutical composition for transdermal administration to a human or lower animal subject comprising a safe and effective amount of a pharmacologically active...
|
|
|
5380757 |
Method of treating vulvar dystrophy and vaginal dryness
Gamma-linolenic (GLA) and/or dihomo-gamma-linolenic acid (DGLA) may be used in the treatment of vulvar dystrophy and/or vaginal dryness. Other essential fatty acids of the n-6 or n-3 series may...
|
|
|
5378730 |
Permeation enhancer comprising ethanol and monoglycerides
Mixtures of ethanol and monoglyceride are disclosed for enhancing the permeation of drugs through skin or mucosa. The monoglyceride is a monoglyceride or a mixture of monoglycerides of fatty acids...
|
|
|
5378732 |
Method of reducing the rate of reocclusion of arteries
Gamma-linolenic acid and/or dihomo-gamma-linolenic acid is used in a medicament for reducing the rate of reocclusion of an artery from which an occlusion or other blockage has been removed, or for...
|
|
|
5362751 |
Tracheobronchodilator using 16-substituted PGEs
The present invention provides a tracheobronchodilator comprising 15-keto-PGEs, reduced in stimuli against bronchi and other side effects.
|
|
|
5354565 |
Biocide activator
A biocide composition comprising (A) 1 to 50% by weight of a biocide, and (B) 0.005-60% by weight of a biocide activator having the specific formula is provided. The biocide effect of a...
|
|
|
5352700 |
Use of essential fatty acids for the preparation of a drug for the treatment of infantile seborrheic eczema
The use of essential fatty acids having 18-20 carbon atoms for producing a pharmaceutical preparation for the treatment of infantile seborrhoeic eczema or asteatotic eczema.
|
|
|
5352697 |
Storage stable pesticide compositions comprising azadirachtin and epoxide
Storage-stable pesticide compositions comprising azadirachtin or an azadirachtin derivative as the active ingredient and an epoxide as the stabilizing agent.
|
|
|
5331009 |
Pharmaceutical compositions for treating adrenoleukodystrophy
A composition for the treatment of adrenoleukodystrophy comprises a mixture of erucic acid and less than 20% of C20:1, in the absence of any C24:0 and C26:0 acids (all the acids being as such or in...
|
|
|
5324748 |
Method for enhancement of 1-series PG production
A composition of an effective amount of (a) γ-linolenic acid and/or dihomo-γ-linolenic acid, optionally in association with linoleic and if desired other fat acids, said acids being used if...
|
|
|
5318991 |
Fatty acid treatment to reduce calcium excretion
Reduction of urinary calcium excretion in humans or animals by the administration of GLA or DGLA as much or in salt or other pharmacologically acceptable form, optionally in association with EPA,...
|
|
|
5312834 |
Pharmaceutical composition for treating acne
A pharmaceutical composition for treating acne includes eicosapentaenoic acid and α-linolenic acid, in a weight ratio of 1:0.1 to 20.0 of eicosapentaenoic acid to α-linolenic acid, respectively,...
|
|
|
5308868 |
Teat dip
A teat dip composition useful for the treatment of mastitis in dairy cows. The composition in application form is in the form of an oil-in-water emulsion. The oil phase includes an unsaturated...
|
|
|
5306730 |
Botulinum toxin neutralizer
A botulinum toxin neutralizer comprising at least one fatty acid having the number of carbon atoms of at least 12. Such a fatty acid may be any of saturated fatty acids such as lauric acid,...
|
|
|
5266594 |
Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity
Inhibitors of nitric acid synthase can be used to prevent neurotoxicity mediated through glutamate receptors. Nitric oxide synthase inhibitors can be used therapeutically in the treatment of...
|
|
|
5260067 |
Cytotropic heterogeneous molecular lipids (CHML) and process for preparing the same
A series of cytotropic heterogeneous molecular lipids (CHML) and the method of preparation thereof are disclosed in the invention. CHML provided by this invention is in molecular type, it is an...
|
|
|
5260336 |
Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
Disclosed is a method of minimizing the effects of a catabolic illness in an individual by administering to the individual a diet which is controlled in the type of fatty acid intake. The diet...
|
|
|
5246716 |
Fatty acid-based antifungal composition having residual activity
An environmentally compatible, non-phytotoxic anti-fungal composition is provided having an active ingredient which comprises a fatty acid metal salt having from 4 to 18 carbon atoms. The metal...
|
|
|
5246726 |
Iron-containing composition and method for treatment of cancer
Pharmaceutically acceptable compositions of one or more n-6 or n-3 essential fatty acids, particularly gamma-linolenic acid, dihomo-gamma-linolenic acid, or eicosapentaenoic acid, and assimilable...
|
|
|
5244921 |
Eicosapentaenoic acids and methods for their production
This invention describes a process for producing single cell edible oils containing eicosapentaenoic acid (EPA) from heterotrophic diatoms. The diatoms are cultivated in a fermentor in a nutrient...
|
|
|
5231085 |
Compositions and methods for the enhancement of host defense mechanisms
The invention provides immunostimulatory compositions comprising an aggregate immunostimulatory amount of a) a compound associated with the synthesis of polyamines, b) a nucleobase source, ...
|
|
|
5225447 |
Composition and method for the treatment of sickle cell anemia
The major component of the carbonate fraction of free acids extractable from alfalfa has shown excellent control of symptoms in patients with sickle cell disease. Its structure has been established...
|
|
|
5225441 |
Treatment of periodontal disease
Omega-3, 20-22 carbon atom, hexa- or penta-unsaturated fatty acids are used in the treatment of periodontal disease.
|
|
|
5223271 |
Lithium treatment
The present invention provides a method of treatment and/or prophylaxis of the human or animal body to combat Molluscum Contagiosum, said treatment comprising topically administering a...
|
|
|
5219888 |
Use of retinoids for the treatment of coronary artery disease
A method to increase plasma high density lipoprotein levels for the treatment and prevention of coronary artery disease by administering a therapeutic amount of a retinoid of the general formula:...
|